Study of the relationship between blood pressure variability during 24 hours and pre-thrombotic state in elderly patients with essential hypertension
10.3760/cma.j.issn.1008-6315.2013.13.006
- VernacularTitle:老年原发性高血压患者24 h血压变异性与血栓前状态指标的研究
- Author:
Zhongliang YANG
;
Xiuyun YANG
;
Nailing WANG
;
Baoling SUN
- Publication Type:Journal Article
- Keywords:
Essential hypertension;
Blood pressure variability;
P-selectin;
Fibrinogen;
Plasminogen activator inhibitant-1
- From:
Clinical Medicine of China
2013;29(z1):16-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the characteristics of blood pressure variability during 24 hours and pre-thrombotic state(PTS) in elderly patients with essential hypertension.Methods One hundred cases of old patients with essential hypertension in the department of Cardiology (hypertension group) and 65 controls with normal blood pressure from Punan Health Check Center (control group) were recruited.The systolic and diastolic blood pressure variability (SBPV,DBPV) during 24 h daytime and nighttime were monitored for all subjects by ambulatory blood pressure monitor.The plasma levels of P-selectin (PS),fibrinogen (Fg) and plasminogen activator inhibitor-1 (PAI-1) were measured.Results The systolic blood pressure variability (SBPV) in hypertension group was significantly larger than that of control group (P ＜ 0.05) in daytime,and no significant difference regarding of the diastolic blood pressure variability (DBPV) between two groups.While in nighttime,SBPV and DBPV in hypertension group were significantly higher than those of control group (P ＜ 0.05).The levels of plasma Fg and PAI-1 in hypertension group were significantly higher than those of control group ((2.8 ±0.9) g/L vs.(2.3 ±0.7) g/L and (29.8 ±2.7) μg/L vs.(25.6 ± 1.2) μg/L,respectively).While no significant difference was found between two groups for PS (P ＞ 0.05).Conclusion That indicated pre-thrombotic state including higher blood pressure variability during 24 hours,especially during nighttime in elderly patients with essential hypertension and plasma fibrinogen.
